AB 2283: Rare Disease Ombudsperson and Rare Disease Advisory Council

8 links on this map: who funds them, what they touched, and who lobbied on it. Select anyone to move the map to them.

Start with

and connect to

Every link on this map

The same connections as a table, with the reason each one is here.

Sort by

Connections of AB 2283: Rare Disease Ombudsperson and Rare Disease Advisory Council

Susan Eggman	Sponsors	Susan Eggman sponsored AB 2283: Rare Disease Ombudsperson and Rare Disease Advisory Council.	None
Alexion Pharmaceuticals, Inc.	Lobbied on it	Alexion Pharmaceuticals, Inc. named AB 2283: Rare Disease Ombudsperson and Rare Disease Advisory Council in 3 lobbying reports.	3 reports
Horizon Therapeutics USA	Lobbied on it	Horizon Therapeutics USA named AB 2283: Rare Disease Ombudsperson and Rare Disease Advisory Council in 2 lobbying reports.	2 reports
Boehringer Ingelheim Pharmaceuticals, Inc.	Lobbied on it	Boehringer Ingelheim Pharmaceuticals, Inc. named AB 2283: Rare Disease Ombudsperson and Rare Disease Advisory Council in 1 lobbying report.	1 report
Biotechnology Innovation Organization	Lobbied on it	Biotechnology Innovation Organization named AB 2283: Rare Disease Ombudsperson and Rare Disease Advisory Council in 1 lobbying report.	1 report
California Chronic Care Coalition	Lobbied on it	California Chronic Care Coalition named AB 2283: Rare Disease Ombudsperson and Rare Disease Advisory Council in 1 lobbying report.	1 report
California Life Sciences	Lobbied on it	California Life Sciences named AB 2283: Rare Disease Ombudsperson and Rare Disease Advisory Council in 1 lobbying report.	1 report
Rare Disease Ombudsperson and Rare Disease Advisory Council.	Source records	AB 2283: Rare Disease Ombudsperson and Rare Disease Advisory Council has an explicit source reference to Rare Disease Ombudsperson and Rare Disease Advisory Council..	None

Reporting about the selected subject. Articles are context and do not establish a connection on this map.

Loading coverage…